The programme is supposed to enable up to USD 1.2 billion a year of additional trade by Asian SMEs. The agreement has led to the mapping of more than 10,000 Covid-19 suppliers across the region. This transparency into medical supply chains will enable the financing of critical supplies that may otherwise not be possible, reveals HSBC in a statement, as reported by gtreview.com.
In June 2020, ADB revealed a mapping tool to make global medical supply chains more transparent and trades easier to finance by listing the suppliers of critical Covid-19 goods, including masks, gowns, and ventilators, as well as the manufacturers of components that make those products, and the banks that finance them.
The tool enables governments, banks, investors, and healthcare professionals to trace the companies that make each component in products, avoiding faulty or fake goods which has become an increasing risk since the start of 2020.
Every day we send out a free e-mail with the most important headlines of the last 24 hours.
Subscribe now
We welcome comments that add value to the discussion. We attempt to block comments that use offensive language or appear to be spam, and our editors frequently review the comments to ensure they are appropriate. If you see a comment that you believe is inappropriate to the discussion, you can bring it to our attention by using the report abuse links. As the comments are written and submitted by visitors of the Telecompaper website, they in no way represent the opinion of Telecompaper.